{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:38:16Z","timestamp":1793655496698,"version":"4.5.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T00:00:00Z","timestamp":1690588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejps.2023.106550","type":"journal-article","created":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T01:15:07Z","timestamp":1690679707000},"page":"106550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Biophysical and docking study on the interaction of anticancer drugs encorafenib and binimetinib with human serum albumin"],"prefix":"10.1016","volume":"189","author":[{"given":"Gabriele","family":"Cavalieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Cilurzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Pettorosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mansueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6092-6532","authenticated-orcid":false,"given":"Erik","family":"Laurini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Pricl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106550_bib0001","series-title":"Stages of Melanoma Skin Cancer","year":"2023"},{"key":"10.1016\/j.ejps.2023.106550_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030662","article-title":"Multi-spectroscopic characterization of human serum albumin binding with cyclobenzaprine hydrochloride: insights from biophysical and in silico approaches","volume":"20","author":"Baig","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2023.106550_bib0003","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.ejps.2023.106550_bib0004","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molstruc.2004.05.026","article-title":"Investigation of the interaction between flavonoids and human serum albumin","volume":"703","author":"Bi","year":"2004","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejps.2023.106550_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jpha.2016.07.004","article-title":"Investigation of binding behaviour of procainamide hydrochloride with human serum albumin using synchronous, 3D fluorescence and circular dichroism","volume":"7","author":"Byadagi","year":"2017","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.ejps.2023.106550_bib0006","series-title":"Amber 2021","author":"Case","year":"2021"},{"key":"10.1016\/j.ejps.2023.106550_bib0007","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1038\/s41388-018-0171-x","article-title":"Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations","volume":"37","author":"Dankner","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ejps.2023.106550_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810086","article-title":"Serum Albumin: a Multifaced Enzyme","volume":"22","author":"De Simone","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2023.106550_bib0009","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ejps.2023.106550_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadva.2023.100091","article-title":"Applications of fluorescence spectroscopy in protein conformational changes and intermolecular contacts","volume":"3","author":"Dos Santos Rodrigues","year":"2023","journal-title":"BBA Adv."},{"key":"10.1016\/j.ejps.2023.106550_bib0011","article-title":"European Cancer Information System","year":"2023","journal-title":"\u2018Melanoma_cancer_en.pdf\u2019"},{"key":"10.1016\/j.ejps.2023.106550_bib0012","unstructured":"EMA, 2023. European Medicines Agency. Withdrawal-assessment-report-balimek-binimetinib_en.pdf. https:\/\/www.ema.europa.eu\/en\/documents\/withdrawal-report\/withdrawal-assessment-report-zioxtenzo_en.pdf. Accessed 31 May 2023."},{"key":"10.1016\/j.ejps.2023.106550_bib0013","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/15216540500404093","article-title":"The extraordinary ligand binding properties of human serum albumin","volume":"57","author":"Fasano","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ejps.2023.106550_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/diseases9020028","article-title":"Anti-angiogenic therapy: albumin-binding proteins could mediate mechanisms underlying the accumulation of small molecule receptor tyrosine kinase inhibitors in normal tissues with potential harmful effects on health","volume":"9","author":"Ghinea","year":"2021","journal-title":"Diseases"},{"key":"10.1016\/j.ejps.2023.106550_bib0015","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/nprot.2006.202","article-title":"Using circular dichroism spectra to estimate protein secondary structure","volume":"1","author":"Greenfield","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejps.2023.106550_bib0016","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.sjbs.2021.09.042","article-title":"Molecular modelling studies unveil potential binding sites on human serum albumin for selected experimental and in silico COVID-19 drug candidate molecules","volume":"29","author":"Gurung","year":"2022","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.ejps.2023.106550_bib0017","doi-asserted-by":"crossref","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Cheminformat."},{"key":"10.1016\/j.ejps.2023.106550_bib0018","first-page":"1321","article-title":"Synthesis of a novel p-hydroxycinnamic amide with anticancer capability and its interaction with human serum albumin","volume":"17","author":"Jiao","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejps.2023.106550_bib0019","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejps.2023.106550_bib0020","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.bpj.2008.12.3901","article-title":"Existence of different structural intermediates on the fibrillation pathway of human serum albumin","volume":"96","author":"Juarez","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejps.2023.106550_bib0021","series-title":"Principles of Fluorescence Spectroscopy","first-page":"27","article-title":"Instrumentation for fluorescence spectroscopy","author":"Lakowicz","year":"2006"},{"key":"10.1016\/j.ejps.2023.106550_bib0022","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","article-title":"Combined vemurafenib and cobimetinib in BRAF-mutated melanoma","volume":"371","author":"Larkin","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2023.106550_bib0023","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1039\/b808938h","article-title":"About the albumin structure in solution: cigar Expanded form versus heart Normal shape","volume":"10","author":"Leggio","year":"2008","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejps.2023.106550_bib0024","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jphotobiol.2005.12.017","article-title":"Steady-state fluorescence quenching applications for studying protein structure and dynamics","volume":"83","author":"Matyus","year":"2006","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.ejps.2023.106550_bib0025","doi-asserted-by":"crossref","first-page":"MMT39","DOI":"10.2217\/mmt-2019-0022","article-title":"Epidemiology and survival outcomes in stages II and III cutaneous melanoma: a systematic review","volume":"7","author":"Miller","year":"2020","journal-title":"Melanoma Manag."},{"key":"10.1016\/j.ejps.2023.106550_bib0026","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10953-016-0435-4","article-title":"Influence of taxifolin on the human serum albumin-propranolol interaction: multiple spectroscopic and chemometrics investigations and molecular dynamics simulation","volume":"45","author":"Mohseni-Shahri","year":"2016","journal-title":"J. Solution Chem."},{"key":"10.1016\/j.ejps.2023.106550_bib0027","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1002\/pro.5560041120","article-title":"How to measure and predict the molar absorption coefficient of a protein","volume":"4","author":"Pace","year":"1995","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejps.2023.106550_bib0028","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera - a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejps.2023.106550_bib0029","unstructured":"Pfizer, 2023. Pfizer Medical Information. BRAFTOVI\u00aeClinical Pharmacology (encorafenib) | Pfizer Medical Information - US. https:\/\/www.pfizermedicalinformation.com\/en-us\/braftovi\/clinical-pharmacology. Accessed 25 May 2023."},{"key":"10.1016\/j.ejps.2023.106550_bib0030","doi-asserted-by":"crossref","first-page":"20115","DOI":"10.1039\/C4RA17093H","article-title":"Impact of structural stability of cold adapted Candida antarctica lipase B (CaLB): in relation to pH, chemical and thermal denaturation","volume":"5","author":"Rabbani","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejps.2023.106550_bib0031","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ijbiomac.2018.11.053","article-title":"Structure, enzymatic activities, glycation and therapeutic potential of human serum albumin: a natural cargo","volume":"123","author":"Rabbani","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2023.106550_bib0032","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1021\/acs.molpharmaceut.6b01124","article-title":"Biophysical study on the interaction between eperisone hydrochloride and human serum albumin using spectroscopic, calorimetric, and molecular docking analyses","volume":"14","author":"Rabbani","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2023.106550_bib0033","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1007\/s00253-013-5123-3","article-title":"Structural characteristics of thermostable immunogenic outer membrane protein from Salmonella enterica serovar Typhi","volume":"98","author":"Rabbani","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejps.2023.106550_bib0034","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1021\/ml4000063","article-title":"Discovery of dabrafenib: a selective inhibitor of Raf Kinases with antitumor activity against B-Raf-Driven tumors","volume":"4","author":"Rheault","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2023.106550_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-012-0018-5","article-title":"The clinical relevance of plasma protein binding changes","volume":"52","author":"Roberts","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2023.106550_bib0036","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ejps.2023.106550_bib0037","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1021\/bi00514a017","article-title":"Thermodynamics of protein association reactions: forces contributing to stability","volume":"20","author":"Ross","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejps.2023.106550_bib0038","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1021\/acs.molpharmaceut.2c00100","article-title":"Binding of the B-raf inhibitors dabrafenib and vemurafenib to human serum albumin: a biophysical and molecular simulation study","volume":"19","author":"Russi","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2023.106550_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03245784","article-title":"A review on the ligand binding studies by isothermal titration calorimetry","volume":"3","author":"Saboury","year":"2006","journal-title":"J. Iran. Chem. Soc."},{"key":"10.1016\/j.ejps.2023.106550_bib0040","article-title":"Epidemiology of melanoma","volume":"9","author":"Saginala","year":"2021","journal-title":"Med. Sci. (Basel)"},{"key":"10.1016\/j.ejps.2023.106550_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065684","article-title":"State of the art of the molecular biology of the interaction between cocoa and witches' broom disease: a systematic review","volume":"24","author":"Santos","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2023.106550_bib0042","unstructured":"SEER, 2023. Surveillance, epidemiology, and end results; \u2018Melanoma of the Skin - Cancer Stat Facts\u2019. https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html. Accessed 15 June 2023."},{"key":"10.1016\/j.ejps.2023.106550_bib0043","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s40265-018-0963-x","article-title":"Encorafenib and binimetinib: first global approvals","volume":"78","author":"Shirley","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2023.106550_bib0044","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbamem.2013.09.005","article-title":"Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors","volume":"1838","author":"Sridharan","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2023.106550_bib0045","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3389\/fphar.2018.01133","article-title":"Application of ITC-based characterization of thermodynamic and kinetic association of ligands with proteins in drug design","volume":"9","author":"Su","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106550_bib0046","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-1681.1975.tb01826.x","article-title":"Spectroscopic techniques in the study of protein binding. A fluorescence technique for the evaluation of the albumin binding and displacement of warfarin and warfarin-alcohol","volume":"2","author":"Sudlow","year":"1975","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejps.2023.106550_bib0047","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jphotobiol.2018.05.008","article-title":"Characterization of the binding of a novel antitumor drug ibrutinib with human serum albumin: insights from spectroscopic, calorimetric and docking studies","volume":"184","author":"Tang","year":"2018","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.ejps.2023.106550_bib0048","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jpba.2009.03.015","article-title":"Fluorescence spectral resolution of tryptophan residues in bovine and human serum albumins","volume":"50","author":"Tayeh","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2023.106550_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092320","article-title":"Molecular markers and targets in melanoma","volume":"10","author":"Teixido","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2023.106550_bib0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejps.2023.106550_bib0051","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.molstruc.2011.05.023","article-title":"Fluorescence quenching and ligand binding: a critical discussion of a popular methodology","volume":"998","author":"van de Weert","year":"2011","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejps.2023.106550_bib0052","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.scitotenv.2019.06.001","article-title":"Multi-spectroscopic measurements, molecular modeling and density functional theory calculations for interactions of 2,7-dibromocarbazole and 3,6-dibromocarbazole with serum albumin","volume":"686","author":"Wang","year":"2019","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.ejps.2023.106550_bib0053","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jlumin.2018.09.005","article-title":"Comparative studies on biophysical interactions between gambogic acid and serum albumin via multispectroscopic approaches and molecular docking","volume":"205","author":"Wang","year":"2019","journal-title":"J. Lumin."},{"key":"10.1016\/j.ejps.2023.106550_bib0054","doi-asserted-by":"crossref","first-page":"15980","DOI":"10.1074\/jbc.M113.467027","article-title":"Structural mechanism of ring-opening reaction of glucose by human serum albumin","volume":"288","author":"Wang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2023.106550_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27082589","article-title":"A comprehensive investigation of interactions between antipsychotic drug quetiapine and human serum albumin using multi-spectroscopic, biochemical, and molecular modeling approaches","volume":"27","author":"Zargar","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2023.106550_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2021.133139","article-title":"Comparison of the interactions of flupyrimin and nitenpyram with serum albumins via multiple analysis methods","volume":"289","author":"Zhao","year":"2022","journal-title":"Chemosphere"},{"key":"10.1016\/j.ejps.2023.106550_bib0057","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2174\/1381612821666150302113710","article-title":"Studies on drug-human serum albumin binding: the current state of the matter","volume":"21","author":"Zhivkova","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2023.106550_bib0058","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1021\/mp400027q","article-title":"Subdomain IB is the third major drug binding region of human serum albumin: toward the three-sites model","volume":"10","author":"Zsila","year":"2013","journal-title":"Mol. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872300180X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872300180X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:07:42Z","timestamp":1760530062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809872300180X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":58,"alternative-id":["S092809872300180X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106550","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biophysical and docking study on the interaction of anticancer drugs encorafenib and binimetinib with human serum albumin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106550"}}